Substituted Aryl Benzylamines as Potent and Selective Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 3 von Vicker, Nigel, Bailey, Helen V., Day, Joanna M., Mahon, Mary F., Smith, Andrew, Tutill, Helena J., Purohit, Atul, Potter, Barry V. L.

Volltext

Rapid and Efficient Microwave‐Assisted Friedländer Quinoline Synthesis von Bailey, Helen V., Mahon, Mary F., Vicker, Nigel, Potter, Barry V. L.

Volltext

Substituted Aryl Benzylamines as Potent and Selective Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 3 von Vicker, Nigel, Bailey, Helen V., Day, J. M., Mahon, Mary, Tuthill, H. J., Smith, Andrew, Purohit, A, Potter, B. V. L.

Volltext

17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer von Day, Joanna M., Foster, Paul A., Tutill, Helena J., Parsons, Michael F.C., Newman, Simon P., Chander, Surinder K., Allan, Gillian M., Lawrence, Harshani R., Vicker, Nigel, Potter, Barry V.L., Reed, Michael J., Purohit, Atul

Volltext

Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs von Ashton, Michael J, Cook, David C, Fenton, Garry, Karlsson, Jan-Anders, Palfreyman, Malcolm N, Raeburn, David, Ratcliffe, Andrew J, Souness, John E, Thurairatnam, Suga, Vicker, Nigel

Volltext

Design, synthesis and in vitro evaluation of potent, novel, small molecule inhibitors of plasminogen activator inhibitor-1 von FOLKES, Adrian, BROWN, S. David, LEAHY, James W, MACH, Morrison, MATTHEWS, David, PRISBYLLA, Michael P, SANDERSON, Jason, SIMON, Reyna J, TESFAI, Zerom, VICKER, Nigel, WANG, Shouming, WEBB, Robert R, CANNE, Lynne E, CHARLTON, Peter, CHAN, Jocelyn, ENGELHARDT, Erin, EPSHTEYN, Sergey, FAINT, Richard, GOLEC, Julian, HANEL, Art, KEARNEY, Patrick

Volltext

Synthesis of strychnine and the Wieland-Gumlich aldehyde von Magnus, Philip, Giles, Melvyn, Bonnert, Roger, Johnson, Gary, McQuire, Leslie, Deluca, Mark, Merritt, Andrew, Kim, Chung S, Vicker, Nigel

Volltext

17 beta -hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer von Day, Joanna M, Foster, Paul A, Tutill, Helena J, Parsons, Michael F C, Newman, Simon P, Chander, Surinder K, Allan, Gillian M, Lawrence, Harshani R, Vicker, Nigel, Potter, Barry V L, Reed, Michael J, Purohit, Atul

Volltext

Adamantyl carboxamides and acetamides as potent human 11I2-hydroxysteroid dehydrogenase type 1 inhibitors von Su, Xiangdong, Halem, Heather, Thomas, Mark, Moutrille, Cecile, Culler, Michael, Vicker, Nigel, Potter, Barry

Volltext

Synthesis of strychnine via the Wieland-Gumlich aldehyde von Magnus, Philip, Giles, Melvyn, Bonnert, Roger, Kim, Chung S, McQuire, Leslie, Merritt, Andrew, Vicker, Nigel

Volltext

Benzothiazole derivatives as novel inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 von Su, Xiangdong, Vicker, Nigel, Ganeshapillai, Dharshini, Smith, Andrew, Purohit, Atul, Reed, Michael J., Potter, Barry V.L.

Volltext

E-Ring Modified Steroids as Novel Potent Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 von Fischer, Delphine S, Allan, Gillian M, Bubert, Christian, Vicker, Nigel, Smith, Andrew, Tutill, Helena J, Purohit, Atul, Wood, Lynn, Packham, Graham, Mahon, Mary F, Reed, Michael J, Potter, Barry V. L

Volltext

STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model von Day, Joanna M, Foster, Paul A, Tutill, Helena J, Schmidlin, Fabien, Sharland, Christopher M, Hargrave, Jonathan D, Vicker, Nigel, Potter, Barry V L, Reed, Michael J, Purohit, Atul

Volltext

Structure−Activity Relationships for Pyrido-, Imidazo-, Pyrazolo-, Pyrazino-, and Pyrrolophenazinecarboxamides as Topoisomerase-Targeted Anticancer Agents von Gamage, Swarna A, Spicer, Julie A, Rewcastle, Gordon W, Milton, John, Sohal, Sukhjit, Dangerfield, Wendy, Mistry, Prakash, Vicker, Nigel, Charlton, Peter A, Denny, William A

Volltext

Modification of Estrone at the 6, 16, and 17 Positions:  Novel Potent Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 von Allan, Gillian M, Lawrence, Harshani R, Cornet, Josephine, Bubert, Christian, Fischer, Delphine S, Vicker, Nigel, Smith, Andrew, Tutill, Helena J, Purohit, Atul, Day, Joanna M, Mahon, Mary F, Reed, Michael J, Potter, Barry V. L

Volltext

Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors von Su, Xiangdong, Halem, Heather A., Thomas, Mark P., Moutrille, Cecile, Culler, Michael D., Vicker, Nigel, Potter, Barry V.L.

Volltext

Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance von Wang, Shouming, Folkes, Adrian, Chuckowree, Irina, Cockcroft, Xiaoling, Sohal, Sukhjit, Miller, Warren, Milton, John, Wren, Stephen P, Vicker, Nigel, Depledge, Paul, Scott, John, Smith, Lyndsay, Jones, Hazel, Mistry, Prakash, Faint, Richard, Thompson, Deanne, Cocks, Simon

Volltext

Novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1: Templates for design von Allan, Gillian M., Vicker, Nigel, Lawrence, Harshani R., Tutill, Helena J., Day, Joanna M., Huchet, Marion, Ferrandis, Eric, Reed, Michael J., Purohit, Atul, Potter, Barry V.L.

Volltext

Discovery of novel inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 von Su, Xiangdong, Vicker, Nigel, Trusselle, Melanie, Halem, Heather, Culler, Michael D., Potter, Barry V.L.

Volltext

Novel and Potent 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors von Lawrence, Harshani R, Vicker, Nigel, Allan, Gillian M, Smith, Andrew, Mahon, Mary F, Tutill, Helena J, Purohit, Atul, Reed, Michael J, Potter, Barry V. L

Volltext